Physician profile

Ali M Kizilbash

Clinical Cardiac Electrophysiology · Irving, TX

NPI 1104825090

$3,342.75

in general payments reported to CMS, 2019-2025

33 companies · $706 in 2025

The $706 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,132.12

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $719.84 2019-2025
Abbott Laboratories $459.26 2020-2025 Xience Skypoint, Agilis, Jot Dx
E.R. Squibb & Sons, L.L.C. $410.74 2019-2025 Camzyos, Eliquis
Pfizer INC. $344.56 2021-2025
Medtronic, INC. $194.67 2024-2025 Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan, In.Pact Admiral
Boston Scientific Corporation $144.73 2023-2025 Bodyguardian, Resonate El Icd Vr
Philips North America LLC $126.91 2022-2025 (Ck4) Mcot, (Ck7) Extended Holter, Extended Holter
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $119.05 2023-2025 Lifevest
Novo Nordisk INC $111.11 2021-2024 Ozempic, Rybelsus
Heartflow, INC. $65.64 2022
Sanofi-Aventis U.S. LLC $60.46 2019-2024
Shockwave Medical, INC $52.69 2024 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Inspire Medical Systems, INC. $43.16 2023-2024 Inspire
Silk Road Medical, INC. $42.81 2024 Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent
Merck Sharp & Dohme LLC $39.79 2022
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $39.12 2025 Jardiance
Biotronik INC. $35.84 2019
Baxter Healthcare $35.62 2023-2024 Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor
Kestra Medical Technology Services, INC. $28.94 2024 Assure Wcd
Angiodynamics, INC. $26.80 2021-2022
Janssen Pharmaceuticals, INC $26.62 2020-2022
Bardy Diagnostics, INC. $25.00 2019
Atricure, INC. $21.65 2023
Astrazeneca Pharmaceuticals LP $20.81 2025 Farxiga
Lexicon Pharmaceuticals, INC. $20.69 2023 Inpefa
Koya Medical, INC. $20.22 2025 Dayspring, Koya Medical
Cvrx, INC. $17.86 2024 Barostim Neo System
Bayer Healthcare Pharmaceuticals INC. $17.01 2021
Amgen INC. $16.12 2019
Cleerly, INC. $15.75 2025 Cleerly Ischemia, Cleerly Labs
Cashflow Solutions, LLC $14.82 2024 Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White
Kiniksa Pharmaceuticals, LTD. $12.52 2021
Medtronic Vascular, INC. $11.94 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ali M Kizilbash

$3,342.75

in general payments reported 2019-2025

Years
2019-2025
Top company
Novartis Pharmaceuticals Corporation
Context
The $706 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/94950/ali-m-kizilbash

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.